Your shopping cart is currently empty

Dextran sulfate sodium salt (MW 36,000–50,000) is a medium molecular weight polyanionic dextran derivative with strong intestinal epithelial permeability. It is the most commonly used agent for inducing inflammatory bowel disease (IBD) models, effectively inducing both acute and chronic colitis. Its mechanism may involve macrophage dysfunction and gut microbiota dysbiosis. Due to its colonic epithelial toxicity, long-term use can also induce colorectal cancer models.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $30 | In Stock | In Stock | |
| 500 mg | $53 | In Stock | In Stock | |
| 1 g | $77 | In Stock | In Stock | |
| 5 g | $188 | - | In Stock |
| Description | Dextran sulfate sodium salt (MW 36,000–50,000) is a medium molecular weight polyanionic dextran derivative with strong intestinal epithelial permeability. It is the most commonly used agent for inducing inflammatory bowel disease (IBD) models, effectively inducing both acute and chronic colitis. Its mechanism may involve macrophage dysfunction and gut microbiota dysbiosis. Due to its colonic epithelial toxicity, long-term use can also induce colorectal cancer models. |
| In vivo | Method: To induce acute colitis, Dextran Sulfate Sodium Salt (MW 36,000-50,000) was administered via drinking water at a concentration of 2.8% (m/V) for 6 consecutive days (from day 0 to day 6).
Results: Compared with the control group, mice in the DSS-induced colitis group exhibited severe clinical symptoms, including significant weight loss, increased DAI scores, and shortened colon length. H&E staining of colon tissue sections from the DSS group revealed inflammatory cell infiltration, goblet and epithelial cell loss, crypt abscesses, thickened and detached muscular layers, and a marked increase in ulcer formation. Additionally, histopathological analysis showed significant colonic tissue damage. |
| Synonyms | DSS |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | H2O: 100 mg/mL, Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.